The listing below shows our latest News Items and is updated regularly. If you wish to post a news item please select the 'Post News' button on the right. The displayed news feed starts on 1st August 2016. Older items can be found here.
To 'Post Your News' use the button at the top right.
We are pleased to present below all posts archived in 'November 2020'. If you still can't find what you are looking for, try using the search box.
A biotech start-up, whose technology aims to tackle cornea donor tissue shortages and speed up life-changing transplants worldwide, has moved into a specialist lab facility – The Biosphere on Newcastle Helix.
Read the rest of entry »
A company working with experts from the University of Birmingham and King’s College London has been awarded funding by Innovate UK to produce custom-fitted, reusable, medical grade facemasks that will fit all people regardless of age, sex or ethnicity.
23 November 2020: A new approach to treating cancers and other diseases that uses a mechanically interlocked molecule as a ‘magic bullet’ has been designed by researchers at the University of Birmingham.
23 November 2020: Scientists at the University of Birmingham have developed a new sensor to measure weak magnetic signals in the brain, which has the potential to increase understanding of connectivity in the brain, and detect signs of traumatic brain injury, dementia and schizophrenia.
A nasal spray to provide protection against the COVID-19 virus has been formulated by researchers at the University of Birmingham, UK, using materials already cleared for use in humans.
Inivata, a leader in liquid biopsy, today announces the appointment of Dr. Alan Schafer as Chief Technology Officer (CTO), effective immediately. Alan will lead the development of Inivata’s leading InVision® liquid biopsy technology platform and new product development.
Key player in the biotech industry and a multimillion-pound Scottish success story, the Intelligent Tissue Group (ITG) has launched Intelligent Clinical – a clinical trials facility set up to assess the safety and effectiveness of new treatments and health-related products by pharmaceutical, medical device and food manufacturing companies.
AMSBIO reports how the internationally renowned Hans Clevers Lab at the Hubrecht Institute, Netherlands used their CELLBANKER® reagent when they needed to freeze down their organoids at short notice ahead of the COVID-19 spring lockdown.
TBAT Innovation Ltd are proud to welcome 5 new members to their team and celebrate their continued growth throughout this pandemic.
APEIRON Biologics AG, a privately-held biotech company developing breakthrough therapies to treat cancer and respiratory conditions, has selected Domainex Ltd to provide integrated lead optimisation services in order to advance the development of inhibitors for the E3 ubiquitin ligase Cbl-b through small molecule drug discovery.
OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.